Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.16 USD | +1.48% | +57.05% | +44.29% |
May. 15 | B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating | MT |
May. 14 | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.29% | 572M | |
+32.36% | 694B | |
+29.59% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.47% | 239B | |
-3.56% | 209B | |
+10.06% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- Harrow Collaborating With Three Health Technology Platforms for US Launch of Vevye